Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The EORTC QLU-C10D: the Hong Kong valuation study.
Xu RH, Wong EL, Luo N, Norman R, Lehmann J, Holzner B, King MT, Kemmler G; EORTC QLG. Xu RH, et al. Among authors: king mt. Eur J Health Econ. 2023 Sep 28. doi: 10.1007/s10198-023-01632-4. Online ahead of print. Eur J Health Econ. 2023. PMID: 37768519
Danish value sets for the EORTC QLU-C10D utility instrument.
Lehmann J, Rojas-Concha L, Petersen MA, Holzner B, Norman R, King MT, Kemmler G; EORTC Quality of Life Group. Lehmann J, et al. Among authors: king mt. Qual Life Res. 2024 Mar;33(3):831-841. doi: 10.1007/s11136-023-03569-w. Epub 2024 Jan 6. Qual Life Res. 2024. PMID: 38183563 Free PMC article.
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.
Pilz MJ, Seyringer S, Al-Naesan I, King MT, Bottomley A, Norman R, Schlosser L, Hell T, Gamper EM; EORTC Quality of Life Group. Pilz MJ, et al. Among authors: king mt. Pharmacoecon Open. 2024 May 2. doi: 10.1007/s41669-024-00484-9. Online ahead of print. Pharmacoecon Open. 2024. PMID: 38696019 Free article.
Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group.
Nielsen LK, Schjesvold F, Möller S, Guldbrandsen N, Hansson M, Remes K, Peceliunas V, Abildgaard N, Gregersen H, King MT. Nielsen LK, et al. Among authors: king mt. J Patient Rep Outcomes. 2024 Feb 5;8(1):15. doi: 10.1186/s41687-024-00691-2. J Patient Rep Outcomes. 2024. PMID: 38315268 Free PMC article. Clinical Trial.
A hard truth to swallow: critically evaluating the MD Anderson Dysphagia Inventory (MDADI) as an endpoint in human papillomavirus-associated oropharyngeal cancer trials.
McDowell L, King MT, Hutcheson KA, Ringash J, Yom SS, Corry J, Henson C, Mehanna H, Rischin D. McDowell L, et al. Among authors: king mt. Int J Radiat Oncol Biol Phys. 2024 May 11:S0360-3016(24)00628-X. doi: 10.1016/j.ijrobp.2024.05.005. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38740309 Review.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Roncolato F, King MT, O'Connell RL, Lee YC, Joly F, Hilpert F, Lanceley A, Yoshida Y, Bryce J, Donnellan P, Oza A, Avall-Lundqvist E, Berek JS, Ledermann JA, Berton D, Sehouli J, Kaminsky MC, Stockler MR, Friedlander M. Roncolato F, et al. Among authors: king mt. Gynecol Oncol. 2024 Feb 26;185:128-137. doi: 10.1016/j.ygyno.2024.02.025. Online ahead of print. Gynecol Oncol. 2024. PMID: 38412736 Free article.
329 results